Take Our Cataract Self-Test

Take Our LASIK Self-Test

Clinical Trials

Dr. Tyson is dedicated to providing the highest quality of patient care and the research department is an integral part of our practice. As a participant in clinical research, our practice is approached by pharmaceutical and device companies specializing in ophthalmology to conduct clinical studies. We are committed to conducting clinical studies that evaluate new medications and surgical innovations (procedures and devices.) It’s exciting to work in conjunction with other researchers in the quest to find the safest and most effective medications and treatments to preserve and restore vision due to ocular diseases and conditions.

PATIENT SAFETY:

To ensure the rights and safety of our research patients, the clinical studies are overseen by the Food and Drug Administration and national Independent Review Boards. Clinical research offers great opportunity to patients, but just like with any medication or surgery there is some degree of risk. The physicians and staff at Eye Associates always put the safety and welfare of our patients first when deciding participation in FDA supported clinical studies.

OUR PHILOSOPHY:

Patients’ happiness, overall satisfaction, and health interests are vitally important to us. Your participation in a clinical trial may or may not benefit you directly, but your involvement helps advance ophthalmology care for the general population in the future.

The commitment of our physicians and staff allows our practice to provide and maintain the highest quality of care for each of our valued patients. If you are interested in learning more, feel free to ask us for information on our current clinical trials.

Sponsor / Study
 here
Title:
SANTEN INCORPORATED

A RANDOMIZED, DOUBLE-MASKED, PARALLEL-GROUP, MULTICENTER STUDY ASSESSING THE SAFETY AND EFFICACY OF DE-117 OPHTHALMIC SOLUTION 0.002% ONCE DAILY AND TWICE DAILY IN SUBJECTS WITH PRIMARY OPEN ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Protocol Number:SPECTRUM 6 STUDY
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
CARL ZEISS MEDITEC

A MULTI-CENTER, PROSPECTIVECLINICAL TRIAL TO EVALUATE THE SAFETY AND EFFECTIVENESS OF THE CT LUCIA 611P POSTERIOR CHAMBER INTRAOCULAR LENS FOR CORRECTION OF APHAKIA FOLLOWING CATARACT REMOVAL (IDE 611 STUDY)
Protocol Number:CT LUCIA 611 ONT-301-17
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
LENSTEC INC.

CLINICAL EVALUATION OF THE LENSTEC SBL-3 INTRAOCULAR LENS
Protocol Number:SBL-INI-02-13
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
GLAUKOS CORPORATION

PROSPECTIVE, RANDOMIZED PHASE 3 STUDY COMPARING TWO MODELS OF TRAVOPROST LNTRAOCULAR IMPLANT TO TIMOLOL MALEATE OPHTHALMIC SOLUTION, USP, 0.5%
Protocol Number:GC-010
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
OCULAR THERAPEUTIX, INC.

A PROSPECTIVE, MULTICENTER, RANDOMIZED, PARALLEL-ARM, DOUBLE MASKED, VEHICLE CONTROLED PHASE 3A STUDY EVALUATING THE SAFETY AND EFFICACY OF OTX-TP IN THE TREATMENT OF SUBJECTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION
Protocol Number:OTX-16-002
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
ALCON

TO DEMONSTRATE THAT THE RATE OF CLINICALLY RELEVANT COMPLICATIONS ASSOCIATED WITH CYPASS MICRO-STENT PLACEMENT AND STABILITY USING THE CYPASS 241-S APPLIER, AS DETERMINED AT 36 MONTHS IN THE POST-MARKET SETTING, IS LESS THAN THE PRE-SPECIFIED PERFORMANCE TARGET WHICH IS BASED ON EXPERIENCE WITH THE CYPASS MODEL E APPLIER IN THE COMPASS (TMI-09-01) TRIAL.
Protocol Number:GLD122c-C001
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study
 here
Title:
TRANSCEND MEDICAL, INC.

AN EXTENSION OF THE ORIGINAL STUDY TMI-09-01. A PROSPECTIVE, RANDOMIZED, COMPARATIVE, MULTICENTER CLINICAL STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE TRANSCEND CYPASS GLAUCOMA IMPLANT IN PATIENTS WITH OPEN ANGLE GLAUCOMA UNDERGOING CATARACT SURGERY (THE COMPASS TRIAL)
Protocol Number:TMI-09-01-E
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
OCULAR THERAPEUTIX, INC.

DEXTENZA CLINICAL STUDY. A PROSPECTIVE, MULTICENTER, RAMDOMIZED, PARALLEL-ARM, DOUBLE-MASKED, VEHICLE CONTROLLED PHASE 3 STUDY EVALUATING THE SAFETY AND EFFICACY OF DEXTEZA FOR TREATMENT OF OCULAR INFLAMMATION AND PAIN AFTER CATARACT SURGERY.
Protocol Number:OTX-15-003
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
GLAUKOS CORPORATION,

A PROSPECTIVE, RANDOMIZED, SINGLE-MASKED, CONTROLLED, PARALLEL GROUPS, MULTI CENTER CLINICAL INVESTIGATION OF A GLAUKOS TRABECULAR MICRO-BYPASS STENT SYSTEM IN CONJUNCTION WITH CATARACT SURGERY.
Protocol Number:GC-008
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
WAVETEC VISION SYSTEMS, INC.

A MULTI-CENTER, PROSPECTIVE, EVALUATION OF REAL-TIME IMAGES CAPTURED ON APHAKIC EYES UTILIZING THE OPTIWAVE™ REFRACTIVE ANALYSIS ABERROMETER (ORA SYSTEM™).
Protocol Number:WA-12-001 (ALPHA)
Principal

Investigator:
Sydney Tyson, MD, MPH
Sponsor / Study

Title:
TRANSCEND MEDICAL, INC.


A PROSPECTIVE, RANDOMIZED, COMPARATIVE, MULTICENTER CLINICAL STUDY TO ASSESS THE SAFETY AND EFFECTIVENESS OF THE TRANSCEND CYPASS GLAUCOMA IMPLANT IN PATIENTS WITH OPEN ANGLE GLAUCOMA UNDERGOING CATARACT SURGERY (THE COMPASS TRIAL)
Protocol Number:TMI-09-01
Principal Investigator:Sydney Tyson, MD, MPH
Sponsor / Study

Title:
ALCON RESEARCH

A COMPARATIVE STUDY OF OLOPATADINE 0.2% VERSUS VEHICLE IN PATIENTS WITH SEASONAL ALLERGIC CONJUNCTIVITIS OR RHINOCONJUNCTIVITIS
Protocol Number:C-04-60
Principal Investigator:Sydney Tyson, MD, MPH
Sponsor / Study

Title:
ABBOTT MEDICAL OPTICS, INC.
Tecnis Multifocal 1-Piece IOL Evaluation Registry
Protocol Number:Post-market Observational Study Only, US
Principal Investigator:Sydney Tyson, MD, MPH
Sponsor / Study

Title:
FORSIGHT VISION5, INC.

AMULTI-SITE QUESTIONAIRE-BASED STUDY TO ASSESS ATTITUDES REGARDING CURRENT IOP-LOWERING EYEDROPS AND PRODUCTS IN DEVELOPING FOR SUSTAINED RELEASE OF MEDICATION IN GLAUCOMATOUS AND OCULAR HYPERTENSIVE SUBJECTS
Protocol Number:FSVE-MKT-001
Principal Investigator:Sydney Tyson, MD, MPH

 

Our Services

Ask A Question

  • This field is for validation purposes and should be left unchanged.
Vineland

251 S. Lincoln Ave.
Vineland, NJ 08361

(856) 691-8188

Blackwood

Blackwood Medical Center
141 S. Black Horse Pike
Blackwood, NJ 08012

(856) 227-6262

Cherry Hill

South Jersey Medical Center
1401 Rte. 70 E, Suite 18
Cherry Hill, NJ 08034

(856) 428-5797

Hammonton

Sail Lake Professional Center
650 S. White Horse Pike, Suite A
Hammonton, NJ 08037

(609) 567-2355

Mays Landing

Shore Health Park
5401 Harding Highway
Mays Landing, NJ 08330

(609) 909-0700

SurgiCenter of Vineland

251 S. Lincoln Ave.
Vineland, NJ 08361

(856) 691-8188

© Eye Associates Surgi Center. All Rights Reserved. Medical Website Marketing by Market3, A NJ Marketing Firm
Section 1557 - Affordable Care Act
The material contained on this site is for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment.
Always seek the advice of your physician or other qualified health care provider.
Veiw Our Areas Covered.
© Eye Associates SurgiCenter of Vineland, 2017 - 2019